Previous 10 | Next 10 |
Image source: The Motley Fool. Minerva Neurosciences Inc (NASDAQ: NERV) Q4 2019 Earnings Call Mar 9, 2020 , 8:30 a.m. ET Operator Continue reading
Minerva Neurosciences, Inc. (NERV) Q4 2019 Earnings Conference Call March 09, 2020 8:30 AM ET Company Participants William Boni - Vice President of Investor Relations & Corporate Communications Remy Luthringer - Executive Chairman & Chief Executive Officer Geoff Race - Ex...
Minerva Neurosciences (NASDAQ: NERV ): Q4 GAAP EPS of -$0.77 misses by $0.39 . More news on: Minerva Neurosciences, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Company confirms timing of expected top-line results from Phase 3 roluperidone trial in Q2 2020 Management to host conference call today at 8:30 a.m. Eastern Time WALTHAM, Mass., March 09, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharm...
WALTHAM, Mass., Feb. 28, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat unmet medical needs of central nervous system (CNS) disorders, today announced that it will ho...
WALTHAM, Mass., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies addressing high unmet medical needs in the treatment of central nervous system (CNS) disorders, today announced th...
WALTHAM, Mass., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies addressing high unmet medical needs in the treatment of central nervous system (CNS) disorders, today announced th...
Gainers: Southwest Georgia Financial (NYSEMKT: SGB ) +48% . More news on: Southwest Georgia Financial Corporation, Rite Aid Corporation, Paratek Pharmaceuticals, Inc., Stocks on the move, Read more ...
Minerva Neurosciences (NASDAQ: NERV ) -24% after MIN-117 flunks mid-stage depression study. More news on: Minerva Neurosciences, Inc., Apogee Enterprises, Inc., Xperi Corporation, Stocks on the move, Read more ...
Gainers: REVG +6.9% . MU +3.4% . PCG +2.2% . OBSV +2.8% . DERM +1.1% . More news on: REV Group, Inc., Micron Technology, Inc., PG&E Corporation, Stocks on the move, , News on ETFs Read more ...
News, Short Squeeze, Breakout and More Instantly...
Minerva Neurosciences Inc Company Name:
NERV Stock Symbol:
NASDAQ Market:
Minerva Neurosciences Inc Website:
BURLINGTON, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today reported business updates and financial results for the first q...
A look at the top 10 most actives in the United States SoundHound AI Inc. (SOUN) rose 19.3% to $6.86 on volume of 301,330,136 shares Canoo Inc. (GOEV) rose 8.3% to $0.1138 on volume of 118,801,751 shares Ault Alliance Inc. (AULT) rose 19.1% to $0.4642 on volume of 117,184,555 shares Mar...